Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428567 | SCV000527874 | likely benign | not specified | 2016-06-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000871016 | SCV001012609 | likely benign | Tyrosinemia type I | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000871016 | SCV001454594 | likely benign | Tyrosinemia type I | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003912722 | SCV004735633 | likely benign | FAH-related disorder | 2022-08-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |